A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
Clinical trial NCT00792012 · COMPLETED
Trial details
- NCT number
- NCT00792012
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2016-07-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.